Search

everythinglearnresearchcommunity

for

Search:↓

Dupilumab helped improve skin and prevent new lesions in a child with a rare immune disorder and severe eczema.

Tildrakizumab significantly improved recalcitrant lichen planopilaris and frontal fibrosing alopecia.

Olumiant should be covered for severe alopecia areata if certain conditions are met.

Ritlecitinib is more effective and cheaper than baricitinib for treating severe alopecia areata.

Mycophenolate mofetil may improve lupus nephritis remission more than cyclophosphamide but with uncertain safety.

Janus Kinase inhibitors effectively induce remission in Ulcerative Colitis with an acceptable safety profile.

Tofacitinib significantly improved symptoms in a patient with overlapping autoimmune disorders.

Oral tofacitinib can significantly improve recalcitrant lichen planopilaris.

Dupilumab is being tested for many new skin, respiratory, and gastrointestinal conditions.

Ruxolitinib cream effectively targets and treats inflammatory skin diseases.

Pegvaliase effectively reduces blood phenylalanine levels in most PKU patients, but requires personalized plans and good communication to manage side effects.

High CCL11 levels may indicate poor response to baricitinib in severe alopecia areata.

Tranilast successfully treated a man's skin sarcoidosis when other treatments failed.

Pioglitazone usually doesn't effectively treat or cure lichen planopilaris.

Anifrolumab may help improve symptoms in patients with overlapping autoimmune diseases.

Biologic agents can be effective for rheumatic diseases but have risks like infections and require careful monitoring and patient information.

Oclacitinib effectively treated a skin condition in dogs that didn't respond to other immunosuppressants.

Baricitinib helps treat several diseases, including COVID-19, but has side effects and needs careful monitoring.

Budesonide is not effective for maintaining remission in Crohn's disease beyond three months.

Ixekizumab is safe for long-term use with low rates of major heart-related events.

Lokivetmab reduced itching in a dog with skin lymphoma.

Patients with acute and subacute skin lupus respond faster to belimumab than those with chronic skin lupus.

Baricitinib may effectively treat oral lichen planus.

Infliximab improved skin and bowel symptoms in Crohn's disease but caused side effects and the disease returned after stopping treatment.

Cromolyn sodium's effectiveness for treating asthma in children under 2 is unclear, possibly more beneficial for older children, and further research is needed.

The combination therapy is safe and more effective for treating pediatric facial and cervical vitiligo.

The compound zishenqing formula is effective and safe for treating mild to moderate systemic lupus erythematosus.

The Polish Dermatological Society recommends personalized treatment for cutaneous lupus, including lifestyle changes, medications, and monitoring, with specific drugs for severe cases.

Infliximab can trigger lupus-like symptoms in Crohn's disease patients.